Company history
Feb. 2010 | BONAC Corporation founded in Kurume, Fukuoka prefecture |
---|---|
Jul. 2011 | Platform technology patents application submitted for nucleic acid medicine |
Apr. 2012 | Domestic platform technology patents obtained for nucleic acid medicine (nkRNA®, PnkRNA®) |
Jul. 2012 | Tokyo Branch opened in Chuo-ku, Tokyo, to strengthen the sales division following up on acquisitiontof patents |
Dec. 2012 | Endowed chair for advanced medicine at Tokyo Medical University established in Shinjuku-ku, Tokyo |
Feb. 2013 | Bioresearch center in Okinawa opened in Uruma, Okinawa prefecture |
Apr. 2013 | Endowed chair in the Department of Molecular Immunology at the Institute of Industrial Science, the University of Tokyo established in Meguro-ku, Tokyo |
Jun. 2013 | Tokyo Branch relocated in Chiyoda-ku, Tokyo |
Dec. 2013 | Third-party allocation of new shares (capital: 174 million yen) |
Dec. 2015 | Third-party allocation of new shares (capital: 944 million yen) |
Jan. 2016 | Third-party allocation of new shares (capital: 1,424million yen) |
May. 2016 | Tokyo Branch relocated in Uchikanda,Chiyoda-ku,Tokyo |
Jun. 2016 | Third‐party allocation of new shares(Capital:1,477million yen) |
Jul. 2017 Sep. 2017 |
Third – Party allocation of new shares(Capital:3,877million yen) |